Search filters

List of works by Marcel Verbeek

1st Conference Clinical Trials on Alzheimer’s Disease September 17-18-19, 2008 School of Medecine Montpellier, France

article

A Practical Guide to Immunoassay Method Validation

scientific article

A multifunctional ELISA to measure oxidised proteins: oxPin1 in Alzheimer's brain as an example

scientific article

A prediction model to calculate probability of Alzheimer's disease using cerebrospinal fluid biomarkers

scientific article

Addition of MHPG to Alzheimer's disease biomarkers improves differentiation of dementia with Lewy bodies from Alzheimer's disease but not other dementias

scientific article

Age and diagnostic performance of Alzheimer disease CSF biomarkers.

scientific article published on February 2012

Amyloid beta-42 (Aβ-42), neprilysin and cytokine levels. A pilot study in patients with HIV related cognitive impairments.

scientific article published on 21 March 2015

Amyloid-β oligomers relate to cognitive decline in Alzheimer's disease

scientific article published in January 2015

An integrated multi-study analysis of intra-subject variability in cerebrospinal fluid amyloid-β concentrations collected by lumbar puncture and indwelling lumbar catheter

scientific article published on 29 July 2015

Ancillary investigations to diagnose parkinsonism: a prospective clinical study.

scientific article published on 9 November 2014

Animal models of cerebral amyloid angiopathy.

scientific article

Anxiety is related to Alzheimer cerebrospinal fluid markers in subjects with mild cognitive impairment ⬇️

scientific article published on September 7, 2012

Aromatic L-Amino acid decarboxylase deficiency: A new case from Turkey with a novel mutation

scientific article published on April 2014

Association between hypocretin-1 and amyloid-β42 cerebrospinal fluid levels in Alzheimer's disease and healthy controls

scientific article published in December 2012

Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia

scientific article published on 29 November 2017

Autoantibodies to cytosolic 5'-nucleotidase 1A in inclusion body myositis.

scientific article published on 4 March 2013

Biological confounders for the values of cerebrospinal fluid proteins in Parkinson's disease and related disorders

scientific article published on 10 October 2015

Biomarkers in cerebrospinal fluid for synucleinopathies, tauopathies, and other neurodegenerative disorders.

scientific article published in January 2017

CSF Neurofilament Light Chain but not FLT3 Ligand Discriminates Parkinsonian Disorders.

scientific article published on 5 May 2015

CSF biomarker variability in the Alzheimer's Association quality control program

scientific article published on May 2013

CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment.

scientific article published in July 2009

CSF d-serine concentrations are similar in Alzheimer's disease, other dementias, and elderly controls

scientific article published on 23 March 2016

CSF hypocretin-1 levels are normal in patients with amyotrophic lateral sclerosis

scientific article published in October 2009

CSF levels of DJ-1 and tau distinguish MSA patients from PD patients and controls

scientific article published on 12 September 2013

CSF levels of glutamine synthetase and GFAP to explore astrocytic damage in seronegative NMOSD

scientific article published on 26 March 2020

CSF α-synuclein correlates with CSF neurogranin in late-life depression

scientific article published on 31 March 2020

CSF α-synuclein does not differentiate between parkinsonian disorders

scientific article published on 13 January 2011

CSF α-synuclein does not discriminate dementia with Lewy bodies from Alzheimer's disease

scientific article published on January 2010

Carbon-11 labeled tracers for in vivo imaging P-glycoprotein function: kinetics, advantages and disadvantages.

scientific article published on January 2010

Cerebral level of vGlut1 is increased and level of glycine is decreased in TgSwDI mice

scientific article published in January 2014

Cerebrospinal Fluid Galectin-1 Levels Discriminate Patients with Parkinsonism from Controls

scientific article published on 21 November 2018

Cerebrospinal Fluid NrCAM is not a Suitable Biomarker to Discriminate between Dementia Disorders--A Pilot Study.

scientific article

Cerebrospinal fluid analysis in the workup of GLUT1 deficiency syndrome: a systematic review

scientific article

Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry

scientific article published on 27 October 2017

Cerebrospinal fluid glucose and lactate: age-specific reference values and implications for clinical practice

scientific article published in 2012

Cerebrovascular and amyloid pathology in predementia stages: the relationship with neurodegeneration and cognitive decline

scientific article published on 29 December 2017

Comparison of Different Matrices as Potential Quality Control Samples for Neurochemical Dementia Diagnostics

scientific article published in March 2016

Consensus guideline for the diagnosis and treatment of aromatic l-amino acid decarboxylase (AADC) deficiency.

scientific article published on 18 January 2017

Correction to: Cerebrovascular and amyloid pathology in predementia stages: the relationship with neurodegeneration and cognitive decline.

scientific article

Diagnosis of progressive supranuclear palsy: can measurement of tau forms help? ⬇️

scientific article published on October 13, 2010

Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis

scientific article published on 17 June 2019

Dickkopf-related protein 3 is a potential Aβ-associated protein in Alzheimer's Disease

scientific article

Disease specificity of autoantibodies to cytosolic 5'-nucleotidase 1A in sporadic inclusion body myositis versus known autoimmune diseases

scientific article

Effect of 1 night of total sleep deprivation on cerebrospinal fluid β-amyloid 42 in healthy middle-aged men: a randomized clinical trial.

scientific article published on August 2014

Fluid biomarkers in multiple system atrophy: A review of the MSA Biomarker Initiative.

scientific article published on 15 May 2015

GLUT1 deficiency syndrome into adulthood: a follow-up study

scientific article published on 12 January 2014

Has CXCL13 an added value in diagnosis of neurosyphilis?

scientific article

Hourly analysis of cerebrospinal fluid glucose shows large diurnal fluctuations

scientific article published on 4 March 2016

Hourly variability of cerebrospinal fluid biomarkers in Alzheimer's disease subjects and healthy older volunteers

scientific article published on 31 August 2011

Human prion diseases in the Netherlands (1998-2009): clinical, genetic and molecular aspects

scientific article

Identification of cerebrospinal fluid biomarkers for parkinsonism using a proteomics approach

scientific article published on 30 November 2021

Identification of coronin-1a as a novel antibody target for clinically isolated syndrome and multiple sclerosis

scientific article published in July 2013

Impact of molecular imaging on the diagnostic process in a memory clinic

scientific article

Improved Cerebrospinal Fluid-Based Discrimination between Alzheimer's Disease Patients and Controls after Correction for Ventricular Volumes

scientific article published on January 2017

Inflammation biomarker discovery in Parkinson's disease and atypical parkinsonisms

scientific article published on 17 January 2020

Levels of HVA, 5-HIAA, and MHPG in the CSF of vascular parkinsonism compared to Parkinson's disease and controls.

scientific article

Limitations of the hCMEC/D3 cell line as a model for Aβ clearance by the human blood-brain barrier.

scientific article published on 11 October 2016

Linkage analysis for plasma amyloid beta levels in persons with hypertension implicates Aβ-40 levels to presenilin 2

scientific article published on 08 August 2012

Longitudinal cerebrospinal fluid biomarker trajectories along the Alzheimer's disease continuum in the BIOMARKAPD study

scientific article published on 06 April 2019

MicroRNA-29a Is a Candidate Biomarker for Alzheimer's Disease in Cell-Free Cerebrospinal Fluid.

scientific article published on 21 April 2015

MicroRNAs in Alzheimer's disease: differential expression in hippocampus and cell-free cerebrospinal fluid.

scientific article published on 17 August 2013

MicroRNAs in Cerebrospinal Fluid as Potential Biomarkers for Parkinson's Disease and Multiple System Atrophy.

scientific article published on 14 November 2016

Movement disorders in GLUT1 deficiency syndrome respond to the modified Atkins diet ⬇️

scientific article published on June 25, 2013

Multicenter Analytical Validation of Aβ40 Immunoassays.

scientific article

Multiple Diagnostic Tests Are Needed to Assess Multiple Causes of Dementia

scientific article published on 01 January 2006

Neurofilament ELISA validation

scientific article published on 24 October 2009

Nigrosome-1 on Susceptibility Weighted Imaging to Differentiate Parkinson's Disease From Atypical Parkinsonism: An In Vivo and Ex Vivo Pilot Study

scientific article published on 03 August 2016

Plasma β amyloid and the risk of Alzheimer's disease in Down syndrome

scientific article published on 29 September 2011

Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study

scientific article published on 10 June 2009

Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis

scientific article published on May 2015

Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease

scientific article published on 27 March 2018

Recommendations to standardize preanalytical confounding factors in Alzheimer's and Parkinson's disease cerebrospinal fluid biomarkers: an update

scientific article published on August 2012

Reduced Influence of apoE on Aβ43 Aggregation and Reduced Vascular Aβ43 Toxicity as Compared with Aβ40 and Aβ42

scientific article published on 17 January 2020

Reference measurement procedures for Alzheimer's disease cerebrospinal fluid biomarkers: definitions and approaches with focus on amyloid β42.

scientific article published on August 2012

Replicated evidence of absence of association between serum S100B and (risk of) psychotic disorder

scientific article

Serum S100B: A proxy marker for grey and white matter status in the absence and presence of (increased risk of) psychotic disorder?

scientific article

Serum angiogenin levels are elevated in ALS, but not Parkinson's disease

scientific article published on 29 May 2014

Serum neuron-specific enolase levels from the same patients differ between laboratories: assessment of a prospective post-cardiac arrest cohort.

scientific article published in October 2013

Soluble TLR2 and 4 concentrations in cerebrospinal fluid in HIV/SIV-related neuropathological conditions.

scientific article

Sperm-associated antigen 16 is a novel target of the humoral autoimmune response in multiple sclerosis.

scientific article published in August 2014

Structural biomarkers in the cerebrospinal fluid within 24 h after a traumatic spinal cord injury: a descriptive analysis of 16 subjects

scientific article published on 08 April 2014

Tau Rather than TDP-43 Proteins are Potential Cerebrospinal Fluid Biomarkers for Frontotemporal Lobar Degeneration Subtypes: A Pilot Study.

scientific article published on 23 September 2016

The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers

scientific article published on July 2011

The Central Biobank and Virtual Biobank of BIOMARKAPD: A Resource for Studies on Neurodegenerative Diseases

scientific article

The impact of preanalytical variables on measuring cerebrospinal fluid biomarkers for Alzheimer's disease diagnosis: A review

scientific article published on 23 June 2018

The increasing impact of cerebral amyloid angiopathy: essential new insights for clinical practice.

scientific article published on 26 August 2017

Total glutamine synthetase levels in cerebrospinal fluid of Alzheimer's disease patients are unchanged

scientific article published on 12 December 2014

Upstream SLC2A1 translation initiation causes GLUT1 deficiency syndrome

scientific article published on 5 April 2017

Validation of a quantitative cerebrospinal fluid alpha-synuclein assay in a European-wide interlaboratory study

scientific article published on 15 May 2015

Validation of microRNAs in Cerebrospinal Fluid as Biomarkers for Different Forms of Dementia in a Multicenter Study

scientific article published on 16 April 2016

Validation of soluble amyloid-β precursor protein assays as diagnostic CSF biomarkers for neurodegenerative diseases

scientific article published on 7 January 2016

Variability of CSF Alzheimer's disease biomarkers: implications for clinical practice

scientific article

White Matter Hyperintensities Potentiate Hippocampal Volume Reduction in Non-Demented Older Individuals with Abnormal Amyloid-β.

scientific article published on 20 September 2016

White paper by the Society for CSF Analysis and Clinical Neurochemistry: Overcoming barriers in biomarker development and clinical translation

scientific article published on 15 March 2018

Paulina is supported by:

About Paulina

Help